Upgrade Your Cell-based Assays to 3D!
InSphero Newsletter January 2014
"Hello, I’m Randy Strube, Director of Global Marketing at InSphero. I look forward to helping InSphero continue to set the standard as a technological innovator and scientific leader in 3D microtissue biology. My experience includes 7 years in life sciences marketing and a Ph.D. in cancer biology. I’m thrilled to be on board!"

Webinar: The use of 3D Human Liver Microtissues for Evaluating Repeat Dose Toxicity

Register now for our upcoming 30-minute webinar exploring InSphero toxicology testing services. These built-to-suit services utilize our 3D InSight™ Human Liver Microtissues, which are ideal for assessment of long term repeated-dose toxicity. Don't miss this great educational opportunity and register today at no cost!

Join us at the IVAL Hepatocyte Conference in Boston

Register to attend our scientific and hands-on sessions at the Inaugural Boston Hepatocyte Conference hosted by In Vitro ADMET Laboratories (IVAL) February 24-26. See how our 3D liver models and cell- based assays enable novel applications for ADMET. Find more here.

InSphero talks at Workshop of IT-LIVER in Vienna

Find out more about our multi-cell type 3D microtissues for preclinical drug applications at the workshop “3-Dimensional Cell Cultures and Drug Discovery” organized by IT-LIVER on February 27-28. Full program and other details here.

3D Cultures Display Enhanced Stress-Responsive & Metabolic Gene Expression

Recent research co-authored by InSphero revealed increased, prolonged expression of genes that regulate anti-oxidant defense & glucocorticoid pathways in 3D rat liver microtissues compared to traditional 2D sandwich culture methods. Read more about this Journal of Tissue Science & Engineering publication.

InSphero hires new Director of Global Marketing

InSphero starts 2014 with a new Director of Global Marketing: Randy Strube, Ph.D. joined the company in January 2014 to strengthen InSphero’s marketing team. Read more.

InSphero user group meeting in Cambridge, UK on March 12

InSphero is joining forces with our distributor Cambridge Bioscience to co-host a UK user group meeting. This is a great educational and networking opportunity for anyone working in safety and toxicology testing interested in 3D cell-based assays to make lead compound selection and testing safer and more efficient. View program and free registration here.

InSphero’s Christmas donation goes to visoparents schweiz

Our annual 2013 Christmas donation was dedicated to the project “MotionComposer” of visoparents schweiz. With MotionComposer, multiple handicapped children receive tools and equipment to allow them to freely move their body to access and engage their world in everyday life. Every donation counts, more about visoparents.
Copyright © 2014 InSphero, All rights reserved.